Innovating for a Healthier Tomorrow
Annual Report 2024/2025
"HSA has built and gained momentum through our transformation initiatives in the past few years. With our new expertise, skills and ability to leverage technology and data, we continue on our transformation journey to build a more agile and adaptable workforce."
Messages from Leadership
Insights from our executive team
Professor Benjamin Ong
Chairman, HSA
Chairman's Message
With strengthened digital capabilities, thriving local collaborations, and increasing synergistic international partnerships, I am confident that we are better-equipped to navigate the evolving landscape and will continue to make an impact in the days ahead.
Key Highlights:
- •Strengthened international collaborations with 5 new MOUs
- •Enhanced digital capabilities through SHARE platform
- •Improved regulatory efficiency by 30%
Adj Prof (Dr) Raymond Chua
Chief Executive Officer
CEO's Message
Advancing as a unified organisation, we continue to deliver excellence in service to Singapore and our stakeholders, building towards an increasingly impactful future for HSA.
Key Highlights:
- •Implemented Next-Gen Blood Supply Management System
- •Opened new Bloodbank@One Punggol facility
- •Enhanced forensic capabilities with AI-powered tools
Key Achievements
Celebrating our milestones and certifications
New ISO 9001:2015 Certification
- Sep 2024 Therapeutic Products Branch
- Oct 2024 Innovation Office and Clinical Trials Branch
- Nov 2024 Medical Devices Cluster
Key Performance Indicators
Our impact by the numbers
Total number of health products assessed for safety and efficacy
Total blood donations collected across all facilities
Criminal and civil cases analyzed by our forensic experts
Active partnerships with regulatory authorities worldwide
New clinical trials approved for innovative treatments
Online submissions processed through digital platforms
Total training hours for professional development
Overall stakeholder satisfaction rating
Strategic Initiatives
Driving innovation and excellence
SHARE Digital Platform
A comprehensive digital portal revolutionizing how industry partners interact with HSA for regulatory submissions and approvals.
Next-Gen Blood Supply Management System
Advanced system for tracking and managing blood supply across all public hospitals, enhancing patient safety and operational efficiency.
MOU with Vietnam Metrology Institute (VMI)
Strengthened collaboration between HSA and VMI through knowledge exchange, joint research and the development of regional quality infrastructure.
Divisional Reports
Detailed reports from each division
Health Products Regulation
Ensuring the safety, efficacy, and quality of health products through robust regulatory frameworks and international collaboration.
Health Products Regulation Report(PDF)Key Highlights
- Launched SHARE digital platform for streamlined applications
- Signed 5 new international agreements for regulatory cooperation
- Approved 420 clinical trials for innovative treatments
- Enhanced post-market surveillance with AI-powered analytics
Image Gallery
Staff Showcase
Hear from our dedicated team members
Transformative solutions begin with understanding tomorrow’s needs today. The Advanced Contactless Evidence Submission/Collection System (ACESS) represents HSA’s commitment to innovation in public service delivery. By reimagining evidence management for the digital age, we have created a new standard for operational excellence in forensic services. This system, developed through close collaboration with our stakeholders, demonstrates how we can harness technology to enhance both efficiency and reliability in our critical work.
Moy Hooi Yan
Laboratory Director
Analytical Toxicology Division
Applied Sciences Group
A vibrant workplace culture is built on trust, open dialogue, and the courage to challenge conventions. By fostering an environment where teams feel empowered to challenge conventions and explore new solutions, we have achieved significant milestones—from streamlining our data competitions to creating HSA’s first digital workplace portal. This approach has not only enhanced our efficiency but has also strengthened the bonds within our teams, proving that the best solutions often emerge when we create space for both professional growth and personal connections.
Gabriel Yeo
Director
Strategy and Business Transformation
Corporate Services Group
In health products regulation, excellence means staying ahead of the curve. Through the Digital-All-in-one System (DASH) MVP, we have demonstrated how emerging technologies can enhance regulatory processes while maintaining the highest standards of safety and quality. Our AI-powered medical device classification tool, built on verified data, exemplifies this approach—harnessing machine learning to provide instant, reliable guidance. This is how we are building a smarter, more responsive regulatory environment that serves our stakeholders better.
Wong Woei Jiuang
Assistant Group Director
Medical Devices Cluster
Health Products Regulation Group
Downloads & Resources
Access full reports and supplementary materials
Full Annual Report 2024/2025
Complete annual report with all sections and financial statements
Download(PDF, 15 MB)Health Products Regulation Report
Detailed report on regulatory activities and achievements
Download(PDF, 5 MB)Stay Connected
Subscribe to our newsletter for the latest updates on HSA initiatives and achievements
Subscribe Now